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Introduction
Being small for a given gestational age is considered as clinical manifestation of intrauterine growth retardation. Newborn with birth weight below the 10 th percentage of the same gestational age and genetic background are defined as small for given gestational age (SAG) cases [1, 2] . According to new data from the INTERGROWTH-21st birth weight standard, Child Health Epidemiology Reference Group (CHERG), nearly 20% of all participating newborns were classified as SGA in 14 cohort studies from 10 middle or low-income countries in 2012 [2] . The incidence rate of SGA in 47 cities of China was approximately 6.6% in 2005 [3] . Because of physiological immaturity, SGA babies underwent many hard challenges at later growth.
Compared to normal term newborns, small for gestational age (SAG) infants were developmental delay at height and weight [4] . A multi-center prospective research from European (The North European Small for Gestational Age Study) revealed that insulin sensitivity and secretion affect height and weight growth of SGA children [5, 6] . SGA newborns have an increased risk for neonatal morbidity and mortality, and they are also associated with CNS diseases and metabolic disorders in later life [7] . A recent study from Taiwan showed that the risk of metabolic diseases, such as hypertension, diabetes and/or hyperlipidemia was more than threefold higher in SGA infants [8] .
The rennin-angiotensin-aldosterone system (RAAS) includes two arms: angiotensin converting enzyme (ACE)-Ang II-Ang II type 1 receptor axis and angiotensin converting enzyme 2 (ACE2)-angiotensin (1-7)-Ang (1-7) Mas receptor axis. These two arms were described in the placenta [9, 10] . The ACE2 gene is localized in chromosome Xp22, which contains 18 exons and 17 introns [11] . ACE2-knockout mice have been shown to have higher blood pressures during pregnancy than wild-type mice. In addition, ACE2-knockout mice give birth to growth-restricted offspring [12] . In early study [13] , it was shown that the single nucleotide polymorphisms (SNPs) at A1075G in intron 1, G8790A in intron 3, C28330G in intron 11, and G 36787C in intron 16 were not dedicated themselves to essential hypertension in male and female subjects. Some studies suggested that genetic variants in the ACE2 gene might have its impact on cardiovascular diseases and diabetes mellitus. ACE2 rs2106809 polymorphism was associated with hypertension in Chinese women and Indian adult population [14, 15] . Lieb et al. reported that ACE2 gene rs4646156, rs879922, rs4240157, and rs233575 polymorphisms might be associated with left ventricular mass, septal wall thickness, and left ventricular hypertrophy in hemizygous men [16] . Recent Chinese studies showed that the ACE2 G8790A polymorphism, especially the A allele, was associated with diabetes mellitus type 2 (T2DM) and cerebral stroke (CS) [17] . The rs2074192 and rs2106809 polymorphisms of the ACE2 gene might be determinants of circulating Ang-(1-7) level in female patients with hypertension [18] . Our own recent study in pregnant women showed that serum Ang (1-7) levels in both mothers and their infants were associated with preterm birth [19, 20] . We have not found any studies on the association of maternal SNPs of ACE2 gene with their fetal growth yet, so we conducted this study to know if the ACE2 rs2074192 polymorphism of pregnant women is associated with restricted fetal growth. 
Materials and Methods
Study subjects 898 pregnant women were prospectively recruited to our mother-child study from May, 2009 to November, 2010 at the first Affiliated Hospital, Jinan University, Guangzhou, China. The study was approved by the Ethics Committee of the first Affiliated Hospital of Jinan University. All subjects had the follow-up during pregnancy with informed consent and the delivery in our clinic. Pregnant women with 20 to 40 years old and singleton pregnancy were included. Pregnant women with syphilis, tuberculosis or HIV, HAV, HCV, HDV, HEV, HSV, CMV and toxoplasma gondii infections, drug or alcohol abuse before and during pregnancy, and pregnant women with tumor, congenital, immunological or mental diseases were excluded. Finally, 739 pregnant women met the included criteria and participated in the study. 265 mothers refused to donate umbilical cord blood. After written consent, 474 cord blood were collected (For more details, see Fig. 1 ).
Sample collection and DNA extraction
Maternal peripheral whole blood samples were taken at the first day of ward admission before delivery. The umbilical cord blood samples were collected immediately after delivery. After anticoagulant processed, 1-2mL blood sample was removed and stored at -20°C until DNA extraction. DNA extraction was used by the SIMGEN DNA mini kit (SIMGEN, Hangzhou, China, FCC ID: 3001050).
Genetic analysis ACE2 gene rs2074192 polymorphism was genotyped by polymerase chain reaction (PCR) with primers and sequencing. Forward primer: 5'-GAAGAAACTGGCAAAGGTCCC-3', and reverse primer: 5'-GCCTAGGTGACAGAGCAAGACTCT-3'. The PCR amplicon is 461bp. PCR reaction container included 50µL volume with 36.75µL ddH 2 O, 5uL 10×Buffer, 2uL genomic DNA template, 1uL forward primer (10pmoL/µL), 1uL reverse primer (10pmoL/µL), 4uL dNTP (2.5mM) and 0.25uL EX TAQ HS (5U). PCR was programmed as followed: the initial degeneration at 94°C for 3 minutes, and 40 amplification cycles with degeneration at 93°C for 30 seconds, annealing at 55°C for 45 seconds, elongation at 72°C for 45 seconds and then a final extension at 72°C for 5 minutes (C1000 Thermal cycler, Bio-Rad, American). The PCR products were proved by electrophoresis in 2% agarose gel with 120 Volt for 40 minutes (EPS-300, Tanon, China). DNA sequencing was done by automatic DNA sequencing analyzer (ABI 3730, Applied Biosystems, USA).
Clinical data collection
Databases were recorded from included pregnant women in our clinic. All data such as basic information, birth records, diagnosis, biochemical and immunological assays, Doppler ultrasonographic findings during pregnancy, etc were collected and put to our databases. The criteria of small for gestational age (SGA) babies was according to both international and Chinese diagnosis [21, 22] . Statistical analysis SPSS software version 19.0 was used for data analysis. Quantitative data was analyzed with analysis of variance (ANOVA) or t-Test, and these results were shown as arithmetic Mean±SD. Enumeration data was analyzed with Chi-Square and Fisher's Exact Test. To identify the risk factors of SGA, multiple logistic regression models were used to correct for known confounding factors. Relevant confounding factors of SGA such as maternal age, BMI, gestational age, maternal smoking, gestational diabetes, gestational hypertension, hepatitis B virus infection, infant gender and oligohydramnios were included into the models [23] [24] [25] [26] [27] [28] [29] . Significant difference was defined as P<0.05. Table 1 showed basic information of pregnant women and their newborns in the study. The mean maternal BMI before pregnancy was 20 kg/m 2 . 384 (81.01%) mothers were primiparity. Maternal mean blood pressure at the third trimester was 120mmHg systolic and 73mmHg diastolic, and the mean systolic and diastolic blood pressures at the second trimester was 111 mmHg and 66 mmHg. 220 boys and 254 girls were born to enter into the study. 312 (65.82%) mothers had cesarean delivery in the study. More details were shown in Table 1 .
Results

Basic information
According to ACE2 rs2074192 variants and/or alleles, three groups of CC, CT and TT genotypes have been classified in the mothers and their newborns (Fig. 1) .
Association of ACE2 gene rs2074192 polymorphism with maternal complications
Maternal age, BMI before pregnancy, and gestational age were not associated with the ACE2 gene rs2074192 polymorphisms in neonates (Tables 2, 3 , and 4). Blood pressures as a continuous parameter of the pregnant women at the second and third trimesters was not affected by the rs2074192 polymorphisms (P>0.05 in all cases). Neither maternal nor neonatal ACE2 gene rs2074192 polymorphism was associated with gestational hypertension (P>0.1). Gestational diabetes mellitus, anemia and/or postpartum hemorrhage was not related to the genotypes of both mothers and their neonates (P>0.05).
Association of ACE2 gene rs2074192 polymorphism with fetal growth There were no differences in birth weight, birth length, head circumference, and APGAR scores among three groups of CC, CT and TT genotypes (P≥0.1; Table 5 ). And there were also no differences in incidence rates of preterm birth, low birth weight and fetal distress among three groups of CC, CT and TT genotypes (P≥0.05; Table  5 ). Babies having T allele had higher incidence of SGA compared to babies having CC homozygote (P=0.027, Table 6 ). 21 SGA infants (15 female and 6 male) were shown in Fig. 2 . Six babies had preterm birth, fifteen babies had term birth. Birth weights of 14 SGA babies were below 2500 grams. However, the biometric data of the neonates were no different between CC and CT genotypes versus TT genotype (P≥0.05, Table  7 ). Maternal ACE2 gene rs2074192 polymorphisms were not associated with both maternal complications and fetal growth parameters (data not shown).
Birth weights of 2 female babies were lower than 1500 grams and the two babies were immediately admitted to neonatal ward. One baby with 1300 grams of birth weight had fetal distress. Her mother had preeclampsia with blood pressures of 143/103 mmHg and urine protein of 1.5 g/L, and her level of serum uric acid was 489 µmol/L. She had preterm delivery at 33 th gestational weeks. The other baby had birth weight of 1150 grams born at 30 th gestational weeks and suffered from neonatal asphyxia. Her mother had gestational hypertension of 134/93 mmHg at the third trimester. The two girls were discharged from hospital after two months. Their body weights increased to 2500g and had normal organ function at that time.
High risk factors associated with SGA
Following the t-Test, multivariable logistic regression models were calculated to identify babies having T allele was independently associated with SGA. Multivariable logistic regression models were adjusted for maternal age, BMI, gestational age, maternal smoking, gestational diabetes, gestational hypertension, hepatitis B virus infection, infant gender and oligohydramnios. The final logistic regression model demonstrated an independent association of the ACE2 gene rs2074192 T allele with SGA (OR: 22.93, 95%CI: 1.26～418.77, P<0.05, Table 8 ). 
Discussion
Our study showed for the first time that newborns carrying the ACE2 gene rs2074192 T allele are at higher risk for fetal growth restriction, e.g. SGA infants, whereas the maternal ACE2 gene rs2074192 polymorphism had no association with fetal growth. This association is independent of known risk factors of SGA as shown by multivariate analysis considering confounding factors.
ACE2 is a counterpart of the ACE enzyme in RAAS, capable of cleaving Ang II into biologically active Ang (1-7) . The ACE2 and Ang-(1-7) tissue concentrations in kidneys of pregnant rats are 1.5~2 times higher as compared to non-pregnant rats [30] . Furthermore, Levy eta al. reported that ACE2 mRNA expression in uterus of pregnant rats was significant higher versus non-pregnant rats [31] . If high salt diet was fed in pregnant rats, ACE2 activity in uterus was much higher compared to non-pregnant rats [31] . In the placenta, ACE2 gene expression was positively associated with gestational age from gestational day 12 to day 20 [32] . Few studies of the association between ACE2 and pregnancy outcomes have been reported. Valdés G et al. found that ACE2 gene expression in arterial endothelium of umbilical cord was lower in normal pregnancy compared to pregnancy with preeclampsia [10] . These observations fit very well with the results of our study.
SGA infants are not only at higher risk for perinatal morbidity and mortality, but they are also more likely to develop central adiposity, insulin and leptin resistance, metabolic syndrome such as hypertension and type 2 diabetes mellitus in later life than infants born with normal weight [33] [34] [35] . Infants can compensate for their small birth weight by later catch-up growth exposed to improved nutrition, however rapid childhood growth aggravates the risk of diseases in later life [36] . The pathological mechanisms leading to SGA are complex. Alterations of the endocrine systems during pregnancy, such as a change of rennin-angiotensin system (RAS) combined with genetics, epigenetics and environment [20, 37, 38] factors might play a role. Nineteen single nucleotide polymorphisms (SNPs) were identified by Itoyama et al. in the human ACE2 gene [39] . ACE2 gene SNPs have been dedicated to diseases, such as hypertension, T2DM and T2DM combined with cerebral stroke (CS). It was found that ACE2 gene rs2074192 and rs2106809 rare alleles are associated with reduced circulating Ang-(1-7) levels in 213 female Han Chinese patients [18] . Ang-(1-7) is a peptide which is a vasodilator and has an anti-tumor activity [40] . In a Canadian teenagers' (12-13 years old) study, ACE2 gene SNPs at rs2074192 and rs233575 were associated with increased systolic blood pressures [41] . Furthermore, male Caucasians with ACE2 gene rs2074192 C allele, rs4240157 G allele and rs4646188 T allele who suffered from type 2 diabetes were more likely to be hypertensive [42] . Diabetic patients who had ACE2 gene rs2074192 T allele and rs714205 C allele had higher chance for developing diabetic retinopathy at Shandong Province, China [43] . However, some recent studies from European, East Asian and Australian populations showed no significant associations of ACE2 genotypes with hypertension and diabetes mellitus [13, 16, [44] [45] [46] . We have not found any studies about human ACE2 gene polymorphisms related to fetal growth, e.g. SGA.
To the best of our knowledge, our study is the first to show that neonatal ACE2 rs2074192 T allele was associated with SGA. ACE2 gene-knockout pregnant mice had lower level of Ang-(1-7) in circulation and increased placental Ang II level, and it was associated with lower fetal body weight and length at the 18 th day of gestation [12] . In our previous clinical study, lower maternal and fetal Ang-(1-7) levels in plasma were at high risk for preterm birth [20] . Compared with healthy pregnant women, ACE D allele in pregnant women had an increased risk for giving SGA babies [47] . In a study from Brazil, The Ang II and ACE levels in plasma of boys who were born as SGA were higher (20% of increased levels) than those in boys at term birth [48] .
There are two limitations in our study: 1. the ACE2 activity in peripheral blood and placenta was not analyzed in both mothers and their newborns. 2. The number of mothers and babies was relatively small and this was a single-center clinical study.
Conclusion
The current study it is first to show that the babies with ACE2 gene rs2074192 T allele had a high risk for SGA, which contributes to metabolic syndrome and cardiovascular diseases in later life. The effect is independent of the maternal ACE2 gene.
